|Tested species reactivity||Human, Mouse|
|Published species reactivity||Human|
|Host / Isotype||Rabbit / IgG|
|Immunogen||KLH conjugated synthetic peptide between 32-58 amino acids from the N-terminal region of human ELOVL6|
|Purification||Ammonium sulfate precipitation, Size-exclusion - Dialysis|
|Contains||0.09% sodium azide|
|Storage Conditions||-20° C, Avoid Freeze/Thaw Cycles|
|Tested Applications||Dilution *|
|Flow Cytometry (Flow)||1:10-1:50|
|Immunohistochemistry (Paraffin) (IHC (P))||1:50-1:100|
|Western Blot (WB)||1:1000|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
|Western Blot (WB)||See 1 publications below|
This antibody is predicted to react with chicken and rat based on sequence homology.
Fatty acid elongases (EC 220.127.116.11), such as ELOVL6, use malonyl-CoA as a 2-carbon donor in the first and rate-limiting step of fatty acid elongation.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
t10,c12 conjugated linoleic acid upregulates hepatic de novo lipogenesis and triglyceride synthesis via mTOR pathway activation.
PA5-13455 was used in western blot to study the role of mTOR activation in the mechanism by which conjugated linoleic acid upregulates de novo lipogenesis and triacylglycerol synthesis in a liver cell line
|Go GW,Oh S,Park M,Gang G,McLean D,Yang HS,Song MH,Kim Y||Journal of microbiology and biotechnology (23:1569)||2013|